Glycine
FoundationalPreclinicalAlso known as: Aminoacetic acid, Glycocoll, G, Gly, L-Glycine, Glycin, Aminoessigsäure
Glycine is the simplest amino acid—a single hydrogen atom replacing the typical side chain found in other proteinogenic amino acids—yet it performs an wide range of biological functions. Despite being classified as "non-essential" because humans can synthesize it endogenously from serine and other precursors, mounting evidence suggests glycine is conditionally essential: the synthetic capacity of human tissues falls short of daily functional demands, particularly during periods of stress, injury, aging, and rapid growth.
Overview
At A Glance
Glycine acts through multiple distinct and non-redundant mechanisms, explaining its extraordinarily broad range of biological effects. Understanding these mechanisms clarifies when supplementation is likely to produce clinically meaningful benefit versus when effects will be subt…
Mechanism of Action
Glycine acts through multiple distinct and non-redundant mechanisms, explaining its extraordinarily broad range of biological effects. Understanding these mechanisms clarifies when supplementation is likely to produce clinically meaningful benefit versus when effects will be subtle or absent.
Inhibitory neurotransmission via glycine receptors: Glycine is the primary inhibitory neurotransmitter of the spinal cord and brainstem, operating through chloride-permeable ionotropic glycine receptors (GlyR). Five subunit types (alpha-1 through alpha-4, and beta) assemble into pentameric receptors with region-specific distribution. When glycine binds, the channel opens, permitting chloride influx and neuronal hyperpolarization. This inhibitory action is pharmacologically related to—though distinct from—GABAergic inhibition. Strychnine, the classic glycine receptor antagonist, produces severe muscle rigidity and convulsions by removing this inhibition. Supplemental glycine crossing the blood-brain barrier produces mild additional activation of glycine receptors, contributing to relaxation and sleep effects.
NMDA receptor co-agonism: Glycine is an obligatory co-agonist at N-methyl-D-aspartate (NMDA) glutamate receptors throughout the brain. NMDA receptors require simultaneous binding of glutamate (at the glutamate site) and glycine or D-serine (at the "glycine modulatory site" or GlyB site) for channel opening. This co-agonist requirement is a safety feature preventing excessive NMDA receptor activation that could cause excitotoxicity. Brain glycine levels are tightly regulated by glycine reuptake transporters (GlyT1 and GlyT2); pharmacological manipulation of these transporters is an active drug development target. High-dose supplemental glycine can saturate the GlyT1 transporter and transiently elevate brain glycine, producing measurable effects on NMDA receptor function. This mechanism explains glycine's modest antipsychotic benefits in schizophrenia (where NMDA hypofunction is implicated) and cognitive effects in some populations.
Glutathione synthesis — the GlyNAC rationale: Glycine is one of the three amino acids required for glutathione synthesis (γ-glutamyl-cysteinyl-glycine), along with glutamate and cysteine. While cysteine is typically considered the rate-limiting substrate (addressed by N-acetylcysteine supplementation), aging adults frequently have inadequate glycine availability that also limits glutathione production. The GlyNAC protocol (glycine plus N-acetylcysteine) developed by Sekhar and colleagues addresses both deficiencies simultaneously. Trials in older adults (Kumar 2022; Sekhar 2021) showed restored glutathione levels along with improvements in multiple aging biomarkers including mitochondrial function, insulin resistance, inflammation, oxidative stress, and physical function. This mechanism is particularly relevant to healthy aging applications.
Collagen and connective tissue synthesis: Collagen, the most abundant protein in mammals, is approximately 33% glycine by residue count. Every third position in the collagen triple helix must be glycine because the small hydrogen side chain is the only one that fits at the helix interior. This architectural requirement means daily collagen synthesis depends on adequate glycine availability. Meléndez-Hevia 2009calculated that collagen synthesis alone requires approximately 10 g glycine daily in adults—a requirement that often exceeds endogenous synthesis plus typical dietary intake. Glycine supplementation supports skin structure, joint cartilage, bone matrix (collagen is the organic scaffold for mineralization), tendon and ligament integrity, and wound healing.
Creatine synthesis: Glycine combines with arginine (via arginine:glycine amidinotransferase) to form guanidinoacetate, which is then methylated by guanidinoacetate N-methyltransferase to produce creatine. This endogenous creatine synthesis pathway supplies a fraction of total body creatine (with dietary and supplemental sources providing the rest). Adequate glycine supports optimal endogenous creatine production.
Heme synthesis: Glycine is the initial substrate for heme synthesis, combining with succinyl-CoA via ALA synthase to produce delta-aminolevulinic acid. Adequate glycine supports oxygen-carrying capacity of red blood cells and function of heme-containing enzymes throughout the body (cytochromes, catalase, peroxidases).
Bile acid conjugation: Along with taurine, glycine is one of two amino acids that conjugate bile acids (glycocholate, glycochenodeoxycholate). In humans, glycine conjugation predominates (3:1 glycine:taurine ratio), reflecting species-specific bile chemistry. Adequate glycine supports optimal bile acid pool composition and lipid digestion.
Purine synthesis: Glycine contributes directly to the purine ring (C4, C5, N7 positions), supporting DNA and RNA synthesis during cell division and tissue repair.
Immune function — glycine-gated chloride channels: Macrophages, neutrophils, Kupffer cells, and lymphocytes express functional glycine receptors that, when activated, produce membrane hyperpolarization and reduced activation of these immune cells. High-dose glycine has immunomodulatory effects that have been leveraged in animal models of ischemia-reperfusion injury, sepsis, arthritis, and transplant rejection. In humans, evidence is less strong but suggests glycine may have anti-inflammatory utility in specific clinical contexts.
Detoxification and conjugation reactions: Glycine conjugates with many xenobiotics in phase II liver detoxification (including benzoate, salicylate, and various endogenous metabolites), producing water-soluble conjugates for renal excretion. Adequate glycine supports detoxification capacity.
Gluconeogenesis and glycemic regulation: Glycine can be metabolized to glucose via gluconeogenesis (through conversion to serine and then pyruvate), though this pathway is typically minor compared to other amino acid sources. More importantly, glycine appears to influence glycemic regulation through effects on glucagon, insulin, and possibly GLP-1 release. Supplemental glycine (5-10 g with meals) reduces postprandial glycemic excursions in diabetic patients.
Sleep architecture and body temperature regulation: Glycine's pre-sleep effects (documented in multiple trials by Yamadera, Bannai, Inagawa and colleagues) involve reduction of core body temperature through peripheral vasodilation, concomitant improvements in sleep onset and early-night sleep quality. The mechanism appears to involve NMDA receptor modulation in the hypothalamic suprachiasmatic nucleus affecting thermoregulation.
One-carbon metabolism via the glycine cleavage system: The multi-enzyme glycine cleavage system converts glycine to CO2, NH3, and methylene-tetrahydrofolate, contributing to the one-carbon pool used for methylation reactions, thymidine synthesis, and other processes. This function integrates glycine metabolism with folate, B12, and choline-dependent pathways.
Mitochondrial metabolism: Glycine participates in mitochondrial protein synthesis, heme synthesis (which occurs partially in mitochondria), and the glycine cleavage system (which is mitochondrial). Effects on mitochondrial function may contribute to glycine's healthspan effects in older adults.
Sarcosarcopenia consideration: Older adults with sarcopenia show altered glycine metabolism, with relative deficiency potentially contributing to reduced protein synthesis capacity, increased inflammation, and impaired recovery from stress.
Absorption, distribution, and elimination: Oral glycine is absorbed primarily in the small intestine via sodium-dependent neutral amino acid transporters (e.g., SLC6A20, SLC38A2) and passive diffusion. Bioavailability is high (above 90%). Plasma glycine peaks approximately 1 hour after oral administration; however, plasma glycine does not reliably predict tissue concentrations due to extensive first-pass hepatic metabolism. About 30-40% of absorbed glycine is taken up by the liver; the remainder distributes to tissues including brain, kidney, and skeletal muscle. Brain uptake occurs via large neutral amino acid transporters at the blood-brain barrier, and brain glycine levels rise modestly with high-dose oral supplementation. Elimination occurs primarily through metabolic conversion (glycine cleavage, transamination to serine, or incorporation into proteins) rather than renal excretion. Half-life in plasma is short (1-2 hours) but functional effects may persist longer due to tissue uptake and metabolic conversion.
Overview
Glycine is the simplest amino acid—a single hydrogen atom replacing the typical side chain found in other proteinogenic amino acids—yet it performs an wide range of biological functions. Despite being classified as "non-essential" because humans can synthesize it endogenously from serine and other precursors, mounting evidence suggests glycine is conditionally essential: the synthetic capacity of human tissues falls short of daily functional demands, particularly during periods of stress, injury, aging, and rapid growth. This gap between synthesis and requirement makes dietary glycine practically important, and supplemental glycine emerges as one of the most evidence-based, low-cost, and versatile compounds in the foundational nutrition category. Glycine's biological roles span multiple major categories. It is the most abundant amino acid in collagen, comprising approximately one-third of collagen's amino acid residues (every third residue in the collagen triple helix must be glycine because the small side chain is the only one that fits at the helix interior). It serves as the primary inhibitory neurotransmitter in the spinal cord and brainstem (via glycine receptors), while also acting as an obligatory co-agonist for NMDA glutamate receptors throughout the brain. It is required for synthesis of glutathione (the body's master antioxidant), creatine (for energy metabolism), heme (for oxygen transport), bile acids (for fat digestion), and nucleotide bases (for DNA). It regulates one-carbon metabolism through the glycine cleavage system. It modulates immune function through glycine-gated chloride channels on macrophages and neutrophils. It stabilizes cell membranes, supports detoxification of many xenobiotics, and participates in the transamination reactions central to nitrogen metabolism. Given this biological breadth, it is perhaps not surprising that glycine supplementation has shown benefits across diverse clinical contexts: improved sleep quality (particularly subjective measures and early-night sleep), enhanced glutathione status in aging adults (the basis of the GlyNAC protocol), reduced symptoms in schizophrenia when combined with standard antipsychotics, improved glycemic control in type 2 diabetes, better outcomes after surgery and trauma, improved outcomes in chronic kidney disease, and potentially benefits for skin and joint health via collagen support. Dietary glycine comes primarily from collagen-containing foods—bone broth, slow-cooked meats with connective tissue, skin-on poultry and fish, gelatin desserts, and collagen supplements. Modern dietary patterns, which favor boneless skinless muscle meats over whole-animal consumption with connective tissue, deliver much less glycine than ancestral diets or traditional cuisines. A typical adult on a modern American diet consumes approximately 1.5-3 g glycine daily; Meléndez-Hevia and colleaguescalculated that the body's daily glycine requirement for collagen synthesis alone exceeds 10 g, and total requirement across all functions likely exceeds 15 g daily. This substantial gap is typically filled by endogenous synthesis, but synthetic capacity appears limited, particularly with aging and disease states. Supplementation of 3-10 g daily closes this gap conveniently and inexpensively. For users of BodyHackGuide, glycine represents one of the most underrated foundational supplements. The cost is trivial (pure glycine powder is among the cheapest supplements per gram), the taste is pleasantly sweet (making it easy to consume), the safety profile is excellent (human supplementation doses of 30+ g daily have been tested without significant adverse effects), and the evidence base spans sleep, glutathione/aging biomarkers, glycemic control, and connective tissue support. Common supplementation errors include: (1) assuming glycine effects will be rapid and dramatic—most benefits emerge over weeks of consistent use, (2) mixing up glycine with glucine or other unrelated compounds, (3) using inadequate doses (under 3 g daily often shows minimal effect on sleep), and (4) neglecting dietary sources of glycine in favor of supplementation when both are straightforward. This monograph addresses each of these issues with the specificity needed for informed self-experimentation. For related foundational support, see /compound/creatine, /compound/taurine, /compound/magnesium, and /compound/nac.
Chemical Information
IUPAC Name
Not yet available
CAS Number
Not yet available
Molecular Formula
Not yet available
Molecular Mass
Not yet available
Chemical data is being compiled for this compound.
Dosing & Protocols
Unlock Dosing Protocols
Free account gets you:
- View beginner, intermediate & advanced protocols
- See weight-based dosing calculations
- Access cycle length & frequency data
2,800+ researchers already in
Research
Unlock Research Data
Free account gets you:
- Browse PubMed study summaries
- See clinical trial phases & results
- Access mechanism of action details
2,800+ researchers already in
Interactions
Contraindications
Glycine has one of the cleanest safety profiles among widely used supplements. Absolute contraindications are rare, and most situations requiring caution are relative rather than absolute.
Absolute contraindications:
- Known hypersensitivity to glycine or excipients in a specific product (extremely rare)
- Urea cycle disorders (unless specifically prescribed by specialist)—glycine metabolism can contribute to ammonia load
- Active severe hepatic encephalopathy with elevated ammonia
Strong relative contraindications (medical supervision recommended):
Advanced liver disease (Child-Pugh C): Glycine's contribution to ammonia production through the glycine cleavage system could theoretically worsen encephalopathy. Moderate doses may be acceptable under hepatology supervision.
Advanced chronic kidney disease / dialysis: Altered amino acid handling; dose adjustment likely needed. Consult nephrology.
Acute schizophrenia or acute psychotic states: Chronic high-dose glycine may benefit negative symptoms, but acute decompensated psychosis requires emergency psychiatric management, not supplement introduction.
Pregnancy with very high-dose protocols: Standard doses (3-10 g) considered safe and even beneficial during pregnancy. High-dose protocols (>15 g) should be held or held pending obstetric input.
Trimethylglycine (TMG) / betaine naming confusion: These are different compounds despite the naming. TMG is specifically contraindicated or requires caution in some settings (e.g., very high homocysteine levels without appropriate workup) that don't apply to plain glycine.
Situations requiring careful dose consideration:
Older adults with polypharmacy: Multiple drug interactions (minor but worth considering). Start at lower doses, monitor for sedation.
Patients with sleep apnea (untreated): Glycine's mild sedative effects at higher bedtime doses could theoretically worsen sleep apnea symptoms. Treat underlying sleep apnea (CPAP) before considering glycine for sleep.
Patients on strong CNS depressants (benzodiazepines, opioids, barbiturates): Mild additive sedation possible at higher doses. Consider morning dosing instead of bedtime, or reduce dose.
Type 1 diabetes: Limited data specifically in T1D. Some potential for glycine's insulin-sensitizing effects. Monitor glucose if starting; discuss with endocrinology.
Established cardiovascular disease: Generally well-tolerated; may offer modest benefits. No specific contraindications beyond standard supplement review.
Cancer (active treatment): Complex considerations. Glycine supports glutathione (could reduce chemotherapy efficacy for some agents that rely on oxidative damage) or could support healthy cell function. Discuss with oncology team.
Autoimmune conditions: Generally safe. Some theoretical interest for lupus, rheumatoid arthritis via anti-inflammatory mechanisms; evidence is limited.
Drug interactions requiring attention:
Antipsychotic medications: Glycine has been safely combined with most antipsychotics in schizophrenia trials. Clozapine combinations have been less robustly beneficial but not harmful. Discuss with psychiatry.
Benzodiazepines and barbiturates: Mild additive CNS depression at higher glycine doses. Usually well-tolerated.
Opioid medications: Possible additive sedation. Usually not clinically significant at standard glycine doses.
Alcohol: No specific interaction but both affect CNS and liver. Moderate use of both is acceptable; avoid combining very high doses.
Bile acid sequestrants (cholestyramine, colesevelam): May theoretically reduce glycine absorption. Separate by 2 hours.
Insulin and oral antidiabetics: Potential for additive glucose reduction. Monitor glucose when starting glycine in tightly-controlled diabetics.
Levodopa and Parkinson's medications: Large neutral amino acids compete for blood-brain barrier transport. Theoretically, very high glycine doses could affect levodopa absorption, but clinical significance is typically minimal.
Tricyclic antidepressants: No documented specific interactions.
SSRIs and SNRIs: No documented specific interactions.
NMDA modulators (memantine, ketamine): Glycine is a co-agonist at NMDA receptors. Theoretical interactions; clinical significance unclear. Discuss with prescriber.
Diuretics: No documented specific interactions.
ACE inhibitors and ARBs: No documented specific interactions.
Statins: No documented specific interactions.
Situations where glycine supplementation is NOT recommended:
As a substitute for medical treatment: Glycine is an adjunctive supplement, not a replacement for prescribed medications for serious conditions (diabetes, schizophrenia, kidney disease).
Very young children without specific medical indication: Infant formula contains glycine; pediatric supplementation beyond that is not evidence-based without specialist input.
Acute decompensated liver disease with elevated ammonia: Avoid until ammonia levels stable and specialist guidance available.
Urea cycle disorders: Avoid unless specifically prescribed as part of disorder management.
When to stop glycine supplementation:
Immediate discontinuation warranted for:
- Unexpected severe GI symptoms not responsive to dose reduction
- Excessive sedation interfering with daily function
- Elevated ammonia or signs of hepatic decompensation in patients with liver disease
- Development of new serious medical conditions that may affect amino acid handling
- Pregnancy with doses above 15 g daily unless specifically prescribed
Gradual reduction reasonable for:
- Resolution of original indication
- Desire to reduce supplement burden
- Shift to dietary adequacy (increased dietary collagen, bone broth, etc.)
- Cost considerations
Monitoring recommendations by use case:
Foundational daily (3-10 g): No specific monitoring beyond annual complete health assessment.
GlyNAC protocol (10 g + NAC): Baseline and 3-6 month labs for response assessment: glutathione (if available), inflammatory markers (hsCRP), metabolic panel, physical function.
High-dose therapeutic (>15 g chronically): Monitoring specific to indication. Liver function periodically if prolonged high-dose use.
Schizophrenia adjunctive (30-60 g): Psychiatric monitoring. Occasional labs for metabolic function.
Pre-surgical considerations: Not typically required to hold glycine before surgery given clean pharmacology profile. Discuss with surgical team; some surgeons prefer discontinuation of most non-essential supplements 1-2 weeks preoperatively. Post-surgical resumption after GI function restored.
Dose adjustments:
Renal impairment:
- CrCl >60: no adjustment
- CrCl 30-60: monitor; consider reduction if any symptoms
- CrCl <30: reduce dose; specialist consultation
- Dialysis: specialist input required
Hepatic impairment:
- Compensated cirrhosis: no specific adjustment; potentially beneficial
- Decompensated cirrhosis/encephalopathy: avoid or very careful specialist-supervised use
- Mild-moderate hepatitis: no specific adjustment
Elderly:
- Generally no specific adjustment
- May be particularly responsive to GlyNAC protocol benefits
- Monitor for sedation effects, particularly with bedtime dosing
Pediatric:
- Infant formula contains glycine naturally
- Beyond formula, pediatric dosing should be specialist-directed
- Not recommended for routine pediatric use without clinical indication
Counseling points for new users:
- Expect subtle effects over weeks; glycine is not a rapid-acting supplement for most indications
- Sleep effects may be noticeable within days for some users
- Connective tissue effects take months of consistent use
- GlyNAC protocol effects on biomarkers typically evident at 3-6 months
- Higher doses are not necessarily better; most users do well at 3-10 g daily
- Combine with NAC for glutathione-focused applications
- Combine with collagen for connective tissue focus
- Safety profile is excellent; adjust based on tolerance and response
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
No listings found for Glycine.
Related Compounds
View AllAlpha-Lipoic Acid
FoundationalPreclinicalAlpha-lipoic acid (ALA), also known as thioctic acid or 1,2-dithiolane-3-pentanoic acid, is a sulfur-containing eight-carbon fatty acid derivative synthesized endogenously in mitochondria by lipoic acid synthase (LIAS).
Coenzyme Q10
FoundationalPreclinicalCoenzyme Q10 (CoQ10), also known as ubiquinone-10, ubidecarenone, or simply "coenzyme Q," is a lipid-soluble benzoquinone compound with a 50-carbon isoprenoid side chain (decaprenyl tail) that anchors it within the inner mitochondrial membrane.
Creatine
FoundationalPreclinicalCreatine is the most-researched nutritional supplement in sports science and has emerged over the past decade as a cornerstone compound in the broader longevity conversation, extending beyond its traditional ergogenic applications into cognitive performance, brain health in aging, sarcopenia prevention, bone health, and recovery from traumatic brain injury.
Magnesium
FoundationalPreclinicalMagnesium is the fourth most abundant cation in the human body and the second most abundant intracellular cation after potassium, with approximately 25 grams present in a typical adult—roughly 60% stored in bone, 27% in muscle, 6-7% in other soft tissues, and less than 1% in extracellular fluid including serum.
Omega-3 Fatty Acids
FoundationalPreclinicalOmega-3 fatty acids represent one of the most thoroughly researched nutritional interventions of the past half-century, with thousands of clinical trials, dozens of major meta-analyses, regulatory approvals for specific pharmaceutical preparations, and foundational status in cardiovascular medicine, cognitive health, and inflammatory conditions.
Selenium
FoundationalPreclinicalSelenium is an essential trace mineral first recognized as toxic in livestock grazing on seleniferous soils in the American West (reported by Kit Carson's expedition in the 1850s) and only later, in 1957, identified as essential for mammalian life when Klaus Schwarz discovered it prevented liver necrosis in rats deficient in the newly-described "Factor 3." The subsequent decades revealed that selenium's essentiality derives from its incorporation into approximately 25 distinct selenoproteins in humans, where it appears as the 21st genetically-encoded amino acid selenocysteine (Sec, U) at specific active sites.
Side-by-Side Comparisons
All ComparisonsView Full Dosage Guide →
Protocols, calculator & safety for Glycine
Related Articles
All PostsNasal Nootropics Ranked by Bioavailability [2026]
Nasal delivery offers the fastest onset and highest bioavailability for many nootropics. We rank nasal peptides and sprays by absorption, onset speed, and real-world effectiveness.
4/1/2026Best Nootropics for Sleep — 2026 Research-Backed Guide
The best nootropics for sleep go beyond melatonin. This research-backed guide covers Apigenin, Oleamide, Kavain, Magnesium L-Threonate, DSIP, Ashwagandha, Selank — with 9 PubMed citations, dosing protocols, sleep architecture science, glymphatic system biology, and 5 stack recommendations for every level.
4/1/2026The Complete Guide to Nootropic Delivery Methods
How you take a nootropic matters as much as what you take. This guide breaks down capsules, nasal sprays, sublingual pouches, and transdermal delivery — with bioavailability data, onset times, and product picks for each method.
4/1/2026Research Score
0 PubMed studies
Quality Indicators
Data Completeness
50%Quick Facts
Trial Phase
Preclinical
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Frequently Asked Questions
How much glycine should I take, and what is the best time?
The answer depends on your goal. For sleep quality improvement, the standard tested dose is 3 g taken 30-60 minutes before bedtime, based on trials by Bannai, Yamadera, Inagawa and colleagues (PMIDs 22529837, 16770747). Some users increase to 5-10 g bedtime for more pronounced effect. For GlyNAC-style aging biomarker support, 100 mg/kg (approximately 7-10 g for most adults) split morning and evening, combined with NAC 600-1200 mg daily, follows the Sekhar/Kumar protocol (PMIDs 34918916, 33511389). For connective tissue and collagen support, 5-10 g daily combined with collagen peptides and vitamin C. For type 2 diabetes or metabolic syndrome adjunctive use, 5 g with meals 2-3 times daily (10-15 g total). For foundational wellness, 3-5 g daily is a reasonable maintenance dose. Timing flexibility is high—morning supports glutathione/energy, evening supports sleep and overnight recovery, split doses distribute the effects. Most users tolerate doses up to 15 g daily without issue; higher doses are generally for specific clinical indications. Pair with food to improve tolerance; mixing in water or beverage works well because glycine is naturally sweet. See /compound/nac and /compound/taurine for complementary pairings.
Is the GlyNAC protocol really as effective as the studies suggest?
The Sekhar lab GlyNAC studies (Kumar 2022 PMID 34918916 and Sekhar 2021 PMID 33511389) reported remarkable improvements in older adults (ages 61-80): restored glutathione levels to those of younger subjects, improved mitochondrial function, reduced inflammation and oxidative stress, improved insulin sensitivity, reduced body fat, improved walking speed and grip strength, and favorable changes in multiple aging biomarkers. Effect sizes were substantial—many parameters improved by 20-40% after 16-24 weeks. The question is replicability and generalizability. The original studies were modest in size (approximately 24 subjects each), conducted at a single institution, and have not yet been fully replicated by independent research groups at publication scale. Multiple follow-up and replication studies are ongoing. The GlyNAC protocol is supported by sound mechanistic rationale (glycine and cysteine are both glutathione substrates that become limiting with aging), uses well-established safe compounds at reasonable doses (glycine 100 mg/kg, NAC 100 mg/kg, for about 7 g and 1.2 g respectively in a 70-kg adult), and has plausible biological effects. Current best interpretation: GlyNAC is a low-risk, evidence-based approach to supporting glutathione and healthy aging in older adults, with effect sizes in real-world use likely smaller than published studies but still meaningful. For users under 50 without specific oxidative stress concerns, the rationale is weaker but risk is minimal. See /compound/nac for NAC details.
Does glycine really help sleep, and how does it compare to melatonin?
Yes, glycine improves sleep quality with effect sizes documented in multiple randomized trials (Yamadera, Bannai, Inagawa groups). The typical finding is that glycine 3 g 30-60 minutes before bedtime reduces subjective sleep latency, improves subjective sleep quality, increases early-night slow-wave sleep, and improves daytime alertness the following morning. Polysomnographic studies confirm objective sleep architecture improvements. Mechanism appears to involve peripheral vasodilation (reducing core body temperature, a signal promoting sleep onset) plus modest central effects via glycine and NMDA receptors. Compared to melatonin: (1) Mechanism: melatonin regulates circadian rhythm and signals darkness; glycine improves sleep quality independent of circadian effects; (2) Onset: both act within 30-60 minutes; (3) Dependence: neither produces physical dependence; (4) Evidence base: both well-studied with moderate effect sizes; (5) Combined use: reasonable and synergistic—melatonin resets rhythm, glycine improves quality. For users with primarily circadian issues (jet lag, shift work, delayed sleep phase), melatonin is more targeted. For users with sleep quality issues independent of circadian rhythm (non-restorative sleep, early-night awakenings, light sleep), glycine may be more helpful. Many users benefit from combination: melatonin 0.5-3 mg + glycine 3-5 g + magnesium glycinate 200-400 mg 30-60 min before bed. Glycine is low-cost, low-risk, and worth trying for sleep quality concerns. See /compound/magnesium for magnesium options.
Can I get enough glycine from diet without supplementing?
Yes in principle, but it requires intentional dietary choices. Modern typical American/Western diets provide about 1.5-3 g glycine daily, primarily from animal protein sources. The body's daily glycine requirement for collagen synthesis alone is approximately 10 g (Meléndez-Hevia 2009, PMID 19565307), and total glycine requirement across all functions likely exceeds 15 g daily. Endogenous synthesis fills some of the gap, but adults frequently have a functional shortfall. To increase dietary glycine: (1) Consume bone broth and collagen-rich cuts of meat (oxtail, shank, short ribs); (2) Eat skin-on poultry and fish; (3) Use gelatin in cooking (e.g., in meat stocks); (4) Supplement with collagen peptides (provides 30-33% glycine by weight, so 20 g collagen = 6-7 g glycine); (5) Nose-to-tail eating patterns provide more glycine than muscle-meat-only patterns. Vegetarians have fewer dietary glycine sources (some from legumes and grains, but much less than collagen-rich animal foods). Vegan diets provide very little dietary glycine. For individuals emphasizing connective tissue-rich foods, 10+ g glycine daily from diet is achievable. For those preferring convenient muscle meats and fish without bones/skin, supplementation is a reasonable way to close the gap. The choice between supplementation and dietary modification is largely personal preference; both are valid. For most users, a combination (collagen peptides from food + 3-5 g standalone glycine) is practical.
Will glycine help my skin, joints, and hair?
Glycine is essential for collagen synthesis (about 33% of collagen residues are glycine), making adequate glycine necessary for skin, joint cartilage, and hair matrix (to the extent hair contains keratin rather than collagen). However, supplementation effects on these endpoints are more robust when glycine is combined with complete collagen precursors (proline, hydroxyproline, and other amino acids found in collagen peptides) and cofactors (vitamin C for proline hydroxylation). Standalone glycine alone may provide less dramatic effects than complete collagen supplementation. Typical approach for skin/joint/hair support: (1) 10-20 g collagen peptides daily (provides complete collagen amino acid spectrum); (2) 3-5 g standalone glycine to boost total glycine intake (collagen alone provides glycine in collagen's native ~33% ratio, which may not maximize glycine availability for other functions); (3) 500-1000 mg vitamin C daily (for proline hydroxylation); (4) Consider adding proline 1-2 g for those focusing on connective tissue. Effects on skin elasticity, joint comfort, and nail strength typically emerge over 3-6 months of consistent use. Hair effects are less well-established since hair is predominantly keratin (not collagen), though some users report subjective improvement. For age-related joint comfort, the combination of collagen + glycine + vitamin C + modest weight loss + resistance training produces better outcomes than any single intervention. Glycine alone is a reasonable addition but not a stand-alone solution for connective tissue goals.
Are there any risks of taking glycine long-term?
Glycine has one of the cleanest long-term safety profiles of any widely used supplement. Doses up to 60 g daily have been used in schizophrenia trials for months without systematic serious adverse effects. Typical supplementation doses (3-10 g daily) have been used by millions of people for years without documented long-term harm. Specific long-term considerations: (1) GI tolerance: most users tolerate long-term use without GI issues; some develop loose stools at higher doses; (2) Mild sedation: some users experience ongoing mild sedation at bedtime doses, typically welcome for sleep; (3) Blood sugar: mild glucose-lowering effect may require medication adjustment in tightly-controlled diabetics over time; (4) Ammonia concerns in advanced liver disease: contraindicated or requires specialist oversight in patients with significant hepatic encephalopathy; (5) Theoretical cancer considerations: glycine supports both healthy cell function and potentially cancer cell proliferation; clinical implications unclear; cancer patients should discuss with oncology; (6) Drug interactions: minor overall, but polypharmacy warrants review. For most healthy adults, long-term glycine supplementation at 3-10 g daily appears well-tolerated with minimal risk and plausible benefits. No evidence supports cycling glycine to avoid habituation or adverse effects; continuous use is safe. Periodically reassess whether you're continuing to benefit (every 6-12 months is reasonable). If you're not noticing benefits at 6-12 months, reasonable to discontinue and allocate supplement budget elsewhere.
How is glycine different from magnesium glycinate, and should I take both?
They are different products with overlapping but distinct uses. Glycine (pure or L-glycine) is the amino acid itself—a single compound providing glycine for all its biological functions (sleep, glutathione, collagen, neurotransmission, etc.). Magnesium glycinate is a mineral salt in which magnesium ions are bound to two glycine molecules; it provides both magnesium (for bone, muscle, sleep, cardiovascular, etc.) and glycine, with improved magnesium absorption compared to other magnesium forms. A typical dose of magnesium glycinate 200 mg elemental magnesium provides approximately 1.5 g glycine; 400 mg magnesium provides approximately 3 g glycine. Should you take both? Depends on goals: (1) If your primary goal is magnesium supplementation with some glycine benefit, magnesium glycinate alone at 200-400 mg elemental magnesium is efficient and cost-effective; (2) If your primary goal is higher-dose glycine (5-10+ g daily for sleep, GlyNAC, connective tissue), magnesium glycinate alone cannot provide enough glycine—add standalone glycine powder; (3) If you want both magnesium and high glycine: magnesium glycinate 200 mg + additional standalone glycine 3-7 g daily provides comprehensive support; (4) Pure glycine is more cost-effective than magnesium glycinate per gram of glycine; magnesium glycinate is priced for its mineral content. Many users start with magnesium glycinate for general foundational support, then add standalone glycine when targeting higher-dose sleep or longevity applications. See /compound/magnesium for comprehensive magnesium guidance.
Can glycine affect blood sugar, and is this safe for diabetics?
Yes, glycine has a mild glucose-lowering effect demonstrated in multiple trials in type 2 diabetic patients (Díaz-Flores 2013 PMID 23770713; Ruiz-Ramírez 2014 PMID 24565621). Typical doses of 5-15 g daily produce HbA1c reductions of 0.3-0.5% over 3-6 months—modest but meaningful. The effect is smaller than standard antidiabetic medications (metformin reduces HbA1c by ~1-1.5%) but comparable to dietary interventions. Mechanisms include glucagon suppression, possible GLP-1 enhancement, and improved muscle glucose handling. Safety for diabetics: (1) Generally safe; not associated with significant hypoglycemia; (2) Monitor glucose periodically when starting, especially if on insulin or sulfonylureas where additive effects are more relevant; (3) Continue standard antidiabetic medications—do not substitute glycine for prescribed therapy; (4) Combining with lifestyle (diet, exercise, weight loss) amplifies benefit; (5) Reasonable adjunctive approach for HbA1c reduction. For T1D: less evidence specifically in T1D, but no specific contraindication; discuss with endocrinology. Patients with tightly-controlled diabetes (HbA1c already at target) should watch for over-correction. Patients with uncontrolled diabetes may see meaningful HbA1c reduction; combine with medical care rather than replacing it. For prediabetes and metabolic syndrome, glycine 5-10 g daily plus lifestyle intervention is a reasonable low-risk approach with modest expected benefits. See /compound/metformin for comparison with first-line antidiabetic therapy.
Does glycine interact with antidepressants, anti-anxiety medications, or sleep aids?
Interactions are generally minor and most users can safely combine glycine with common psychotropic medications. Specific considerations: (1) SSRIs and SNRIs (fluoxetine, sertraline, citalopram, venlafaxine, duloxetine): No documented clinically significant interactions. Glycine and these medications work through different systems. Safe to combine. (2) Tricyclic antidepressants (amitriptyline, nortriptyline): No documented specific interactions. Additive sedation at higher glycine doses with bedtime dosing possible. (3) Benzodiazepines (alprazolam, clonazepam, lorazepam, diazepam): Mild additive sedation possible at higher glycine doses. Usually tolerated but consider morning dosing instead of bedtime if excessive sleepiness. (4) Sleep medications (zolpidem, eszopiclone, trazodone, doxepin): Potential additive sedation. Glycine 3 g + zolpidem 5 mg at bedtime is generally well-tolerated; combine thoughtfully. (5) Antipsychotics: Glycine has been safely combined with most antipsychotics in schizophrenia trials; may benefit negative symptoms. Clozapine combinations tolerated but may show less benefit than with other antipsychotics. (6) Mood stabilizers (lithium, valproate, lamotrigine): No documented specific interactions. (7) ADHD medications (stimulants or non-stimulants): No documented interactions. Considerations for combined use: (1) Monitor for excessive sedation; if present, reduce glycine dose or move to different time; (2) Discuss all supplements with prescribing physician; (3) Don't substitute glycine for prescribed psychiatric medications. For users with anxiety disorders, glycine's mild calming effect at 3-5 g doses may provide additional support without significant interaction with prescribed therapy.
What's the ideal long-term glycine regimen for a healthy adult focused on longevity?
For a healthy adult focused on longevity, a reasonable long-term regimen integrates glycine into a broader foundational stack. Base regimen: (1) Glycine 5-10 g daily, typically split morning and evening, powder form for cost efficiency; (2) N-acetylcysteine (NAC) 600-1200 mg daily if over 40 or interested in GlyNAC benefits; (3) Magnesium glycinate 200-400 mg elemental daily (contributes additional glycine); (4) Omega-3 (EPA/DHA) 1-3 g daily; (5) Vitamin D 2000-5000 IU daily; (6) Creatine 3-5 g daily; (7) Taurine 2-3 g daily; (8) Vitamin C 500-1000 mg daily (supports collagen synthesis); (9) Comprehensive B-complex or high-quality multivitamin. Optional additions based on age and interests: (10) Collagen peptides 10-20 g daily if skin/joint focus; (11) CoQ10 100-200 mg if over 50 or on statins; (12) Selenium 200 mcg daily (for glutathione synergy with NAC); (13) Other longevity compounds (NMN, rapamycin, metformin) per separate protocols and medical guidance. Monitoring: (1) Annual comprehensive blood work (CBC, chemistry, lipids, HbA1c, inflammatory markers); (2) Periodic body composition and functional assessments; (3) Aging biomarker testing (epigenetic clocks, GlycanAge) if interested; (4) Subjective tracking of sleep, energy, recovery, mood. Timing: (1) Morning: glycine 3-5 g + NAC 600 mg + vitamin D + omega-3 + creatine + vitamin C + multivitamin with breakfast; (2) Evening: glycine 3-5 g + magnesium glycinate + NAC 600 mg with dinner or 1 hour before bed. Cost: total monthly cost for comprehensive glycine-based longevity stack is typically $50-100 depending on quality choices—among the most cost-effective interventions for healthy aging. See /compound/nmn, /compound/rapamycin, /compound/metformin, and /compound/creatine for related longevity compounds.
Research Tools
Related Compounds
View AllAlpha-Lipoic Acid
FoundationalPreclinicalAlpha-lipoic acid (ALA), also known as thioctic acid or 1,2-dithiolane-3-pentanoic acid, is a sulfur-containing eight-carbon fatty acid derivative synthesized endogenously in mitochondria by lipoic acid synthase (LIAS).
Coenzyme Q10
FoundationalPreclinicalCoenzyme Q10 (CoQ10), also known as ubiquinone-10, ubidecarenone, or simply "coenzyme Q," is a lipid-soluble benzoquinone compound with a 50-carbon isoprenoid side chain (decaprenyl tail) that anchors it within the inner mitochondrial membrane.
Creatine
FoundationalPreclinicalCreatine is the most-researched nutritional supplement in sports science and has emerged over the past decade as a cornerstone compound in the broader longevity conversation, extending beyond its traditional ergogenic applications into cognitive performance, brain health in aging, sarcopenia prevention, bone health, and recovery from traumatic brain injury.
Magnesium
FoundationalPreclinicalMagnesium is the fourth most abundant cation in the human body and the second most abundant intracellular cation after potassium, with approximately 25 grams present in a typical adult—roughly 60% stored in bone, 27% in muscle, 6-7% in other soft tissues, and less than 1% in extracellular fluid including serum.
Omega-3 Fatty Acids
FoundationalPreclinicalOmega-3 fatty acids represent one of the most thoroughly researched nutritional interventions of the past half-century, with thousands of clinical trials, dozens of major meta-analyses, regulatory approvals for specific pharmaceutical preparations, and foundational status in cardiovascular medicine, cognitive health, and inflammatory conditions.
Selenium
FoundationalPreclinicalSelenium is an essential trace mineral first recognized as toxic in livestock grazing on seleniferous soils in the American West (reported by Kit Carson's expedition in the 1850s) and only later, in 1957, identified as essential for mammalian life when Klaus Schwarz discovered it prevented liver necrosis in rats deficient in the newly-described "Factor 3." The subsequent decades revealed that selenium's essentiality derives from its incorporation into approximately 25 distinct selenoproteins in humans, where it appears as the 21st genetically-encoded amino acid selenocysteine (Sec, U) at specific active sites.
Side-by-Side Comparisons
All ComparisonsCompare Glycine head-to-head: mechanism, half-life, dosing, safety, and live pricing.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
